Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-07-02
1981-05-19
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424312, 424314, A61K 3122, A61K 3123
Patent
active
042685249
ABSTRACT:
Abnormally high ratios of low density and very low density lipoproteins to high denisty lipoproteins, an etiological factor in vascular conditions, are reduced by oral or parenteral administration of acylcarnitine which increases the level of high density lipoproteins.
REFERENCES:
patent: 3810994 (1974-05-01), Wiegand
patent: 3968241 (1976-07-01), Defelice
patent: 4032641 (1977-06-01), Chibata
patent: 4075352 (1978-02-01), Defelice
patent: 4194006 (1980-03-01), Cavazza
Challoner, J. Clin. Invst., vol. 51, Aug. 1972, pp. 2071-2076.
Fritz, Chem. Abs., vol. 59, 1963, p. 10403.
Fraenkel, Vitamins & Hormones, Acd. Press, N.Y., vol. XV, 1957, pp. 73-118.
Preziosi, Lipid Pharm., Med. Chem. Series, vol. 2, 1964, Acd. Press, N.Y., pp. 446-450.
Gemelli, Boll. Della Soc. Ital. di. Biol. Sperimen., vol. 50, No. 10, 1974, pp. 667-672.
Bekaert (1) Chem. Abs., vol. 54, 1960, p. 14447e.
Bekaert (2) Chem. Abs., vol. 52, 1958, p. 18851e.
Borniche, Chem. Abs., vol. 54, 1960, p. 14447e.
Branca, Chem. Abs., vol. 87, 1977, Ab. No. 100942y.
LandOfFree
Method of treating abnormal lipoprotein ratios with acylcarnitin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating abnormal lipoprotein ratios with acylcarnitin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating abnormal lipoprotein ratios with acylcarnitin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1489633